20,000-share resale notice — CRGO (NASDAQ: CRGO) filed Form 144

Rhea-AI Filing Summary

CRGO submitted a Form 144 notice indicating proposed sale of 20,000 shares of Ordinary stock on 05/11/2026. The filing notes the shares arose from restricted stock vesting under a registered plan. The excerpt also lists multiple recent open-market sales of Ordinary shares by the reporting holder between 03/11/2026 and 05/06/2026.

Insights

Securities Compliance Analyst

Form 144 documents a proposed resale of vested restricted shares.

The filing records a proposed sale of 20,000 shares dated 05/11/2026

Prior-sale rows show multiple transactions (examples include 04/28/2026 15,000 shares for $30,750 and 05/06/2026 20,000 shares for $41,000), indicating ongoing dispositions by the holder. Cash‑flow treatment is the holder's sale proceeds.

Key Figures

Proposed resale: 20,000 shares Recent sale example: 20,000 shares Recent sale example: 15,000 shares

3 metrics

Proposed resale 20,000 shares Form 144 notice dated <date>05/11/2026</date>

Recent sale example 20,000 shares <date>05/06/2026</date> proceeds <money>$41,000</money>

Recent sale example 15,000 shares <date>04/28/2026</date> proceeds <money>$30,750</money>

Key Terms

restricted stock vesting under a registered plan, Form 144, Issuer

3 terms

restricted stock vesting under a registered plan regulatory

"Restricted stock vesting under a registered plan"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Issuer financial

"Securities To Be Sold ... Issuer"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/11/2026 - 04:14 PM Learn about SEC filing dates

FAQ

What does the CRGO Form 144 say was proposed?

The filing proposes the resale of 20,000 shares of Ordinary stock, dated 05/11/2026. The shares are described as from restricted stock vesting under a registered plan, indicating an issuer-originated compensation source for these shares.

Who appears to have sold CRGO shares recently according to the excerpt?

The excerpt lists multiple open-market dispositions by the reporting holder at the listed address (e.g., transactions on 03/11/2026 through 05/06/2026). Specific rows show individual sale dates, share counts, and gross proceeds in dollars.

Do the rows show prices or proceeds for recent CRGO sales?

Yes. The table includes dollar amounts tied to each sale row (for example, 05/06/2026 20,000 shares for $41,000 and 04/28/2026 15,000 shares for $30,750), listed alongside dates and share counts.

Are the proposed CRGO sales part of compensation vesting?

The filing explicitly states the securities arose from restricted stock vesting under a registered plan and lists the issuer as the source, linking the shares to compensation rather than an external purchase or transfer.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	20000	41017.45	51376890	05/11/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/01/2012	Restricted stock vesting under a registered plan	Issuer			20000	01/01/2012	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/06/2026	20000	41000.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	05/04/2026	20000	41000.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/28/2026	15000	30750.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/17/2026	10000	21300.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/15/2026	10000	18500.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/13/2026	10000	16200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/08/2026	10000	16900.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	04/01/2026	5000	8200.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/30/2026	5000	8150.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/24/2026	10000	15850.00
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/17/2026	10000	16508.50
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/16/2026	10000	15214.04
ZVI SCHREIBER PLANTA 10, AVDA. DIAGONA BARCELONA U3 08018	Ordinary	03/11/2026	5000	6300.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)